heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1)
Showing 1 - 25 of 3,927
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
Not yet recruiting
- Myeloproliferative Neoplasms (MPNs)
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
- (no location specified)
Mar 24, 2023
Benign Breast Tumor, Breast Carcinoma, Malignant Breast Tumor Trial in Los Angeles (Diffusion Weighted Imaging, Magnetic
Completed
- Benign Breast Neoplasm
- +2 more
- Diffusion Weighted Imaging
- Magnetic Resonance Spectroscopic Imaging
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Malignant CNS Tumor Trial in Rochester (drug, other, procedure)
Not yet recruiting
- Malignant Central Nervous System Neoplasm
- Anhydrous Enol-oxaloacetate
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 31, 2023
Primary Brain Tumor Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Spectroscopic Imaging)
Recruiting
- Primary Brain Neoplasm
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Quantitative HP MRI for Clinical Prostate Cancer Exam
Active, not recruiting
- Prostate Adenocarcinoma
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022
Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C
Active, not recruiting
- Prostate Adenocarcinoma
- +9 more
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Malignant Brain Glioma Trial in Atlanta (Magnetic Resonance Spectroscopic Imaging, Proton Therapy)
Recruiting
- Malignant Brain Glioma
- Magnetic Resonance Spectroscopic Imaging
- Proton Therapy
-
Atlanta, Georgia
- +2 more
May 27, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Rochester (Biospecimen Collection, Bone Marrow Aspiration,
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- +7 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 1, 2023
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Biopsy
- +7 more
- (no location specified)
Sep 21, 2023
Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic
Not yet recruiting
- Locally Advanced Intrahepatic Cholangiocarcinoma
- +4 more
- Angiography
- +8 more
-
Jacksonville, FloridaMayo Clinic in Florida
Sep 22, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023
Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +3 more
- Biopsy
- +7 more
- (no location specified)
Nov 9, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen
Not yet recruiting
- Malignant Solid Neoplasm
- +4 more
- Binimetinib
- +6 more
- (no location specified)
Nov 8, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +7 more
-
Aurora, Colorado
- +7 more
Nov 29, 2022
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Malignant CNS Tumor, Metastatic Malignant Tumor in the CNS Trial in Palo Alto (other, drug, procedure)
Suspended
- Malignant Central Nervous System Neoplasm
- Metastatic Malignant Neoplasm in the Central Nervous System
- Gadolinium
- +3 more
-
Palo Alto, CaliforniaStanford University School of Medicine
Aug 2, 2021
Neurodevelopmental Disorders, Intellectual Disability, Developmental Delay Trial in New York
Recruiting
- Neurodevelopmental Disorders
- +6 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 1, 2021
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023